Related Experiment Videos
Delayed life-threatening pneumonitis secondary to procarbazine
B J Brooks1, N B Hendler, S Alvarez
1Ochsner Clinic of Baton Rouge, Louisiana 70816.
American Journal of Clinical Oncology
|June 1, 1990
Abstract:
A patient with advanced Hodgkin's disease being treated with MOPP chemotherapy presented with delayed life-threatening pulmonary toxicity secondary to procarbazine. The pulmonary toxicity began 1 week after procarbazine had been discontinued and once recognized was successfully treated with intravenous steroids.